Latest Commercialization News

Kula Gold has agreed to sell its Westonia Project to Forrestania Resources for an upfront $500,000 plus a $1 million contingent payment tied to resource discovery. This move sharpens Kula’s focus on advancing its Mt Palmer Gold Project.

Delorean Corporation has locked in a $14.5 million lower-cost loan facility with National Australia Bank to fund its SA1 Salisbury Bioenergy Project, refinancing existing debt and freeing capital for further bioenergy developments.

Algorae Pharmaceuticals has secured an exclusive licensing agreement with Sakar Healthcare to introduce five generic oncology medicines in Australia and New Zealand, marking its first commercial foray in the region.

Clover Corp has reported a standout FY25 with robust revenue and profit growth, driven by new product launches and strategic investments that strengthen its global supply chain and market reach.

Clover Corporation posted a robust 38% revenue increase to $86 million in FY25, driven by product innovation and operational gains, while declaring a final dividend. The company’s cautious outlook for FY26 reflects ongoing regulatory and production challenges.

Hazer Group has been granted a pivotal patent in Singapore for its proprietary graphite morphology process, reinforcing its foothold in Southeast Asia's clean energy and advanced manufacturing markets.

Nuix Limited has showcased its strategic AI-driven growth plan centered on the Nuix Neo Platform and Deep Learning Framework, promising enhanced data processing and new regulatory solutions in FY26.

Gumtree Australia Markets Limited has partnered with Australian Community Media to integrate automotive content, cross-list marketplace listings, and offer combined advertising solutions to a shared audience of 7.1 million Australians monthly.

AXP Energy reports encouraging oil and gas shows in its first Oklahoma well, Charlie #1, signaling potential for expanded production and gas-to-power operations.

EBR Systems has secured final CMS approval for Transitional Pass-Through reimbursement for its WiSE CRT System, effective October 1, 2025, enhancing hospital adoption prospects in the U.S.

ReNerve Ltd has launched its Empliq product range, marking its entry into the dermal and amniotic tissue repair markets with first sales already recorded and a US launch planned.

ReNerve Limited has launched its Empliq tissue product range in the US, marking a strategic expansion into the growing dermal and amniotic tissue market. The launch complements its existing nerve repair portfolio and sets the stage for further growth.